2017
DOI: 10.1016/j.jocd.2016.08.010
|View full text |Cite
|
Sign up to set email alerts
|

The Use of the Fracture Risk Assessment (FRAX®) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…It is widely acknowledged that the application of FRAX® should be country-specific. However, as FRAX® has progressively become more widely utilized globally, it was realized that the use of FRAX® not only should be ethics-specific 27 but also should be disease-specific 28 30 when applied in precision medicine. As previously mentioned, RA has been incorporated as a dichotomous predictor in the FRAX®; however, no RA-specific guidelines or recommendations, as of GIOP, 13 , 14 based on FRAX® are available currently.…”
Section: Discussionmentioning
confidence: 99%
“…It is widely acknowledged that the application of FRAX® should be country-specific. However, as FRAX® has progressively become more widely utilized globally, it was realized that the use of FRAX® not only should be ethics-specific 27 but also should be disease-specific 28 30 when applied in precision medicine. As previously mentioned, RA has been incorporated as a dichotomous predictor in the FRAX®; however, no RA-specific guidelines or recommendations, as of GIOP, 13 , 14 based on FRAX® are available currently.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the well-known increased risk of osteoporosis and bone fractures among IBD patients, the WHO FRAX tool has been used in a very limited number of studies in this specific population. After an exhaustive literature search, only 7 documents, 3 of them being abstracts only, have reported on the use of the FRAX tool to estimate the 10-year probability of hip and major osteoporotic fractures in patients with IBDs 19 . Summary estimates have shown a low risk of hip fracture in IBD patients (below a 4% fracture risk after 10 years), and also a modest increase in 10-year probability of suffering a major osteoporotic fracture (below 12%).…”
Section: Discussionmentioning
confidence: 99%
“…Summary estimates have shown a low risk of hip fracture in IBD patients (below a 4% fracture risk after 10 years), and also a modest increase in 10-year probability of suffering a major osteoporotic fracture (below 12%). 19 The potential advantages of using FRAX tool with IBD patients include the fact that it allows the assessment of additional risk factors related to loss of bone mass and associated to IBDs beyond BMD itself, including older age, postmenopausal status, smoking, malnutrition, physical inactivity, corticosteroid use for more than 3 months. 20 Our study highlights the lack of correlation between FRAX score and clinical or endoscopic disease activity, and therapy with immunosuppressants.…”
Section: Discussionmentioning
confidence: 99%